Clinical Trial Update: Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update on dosing of Tenofovir and Efavirenz in antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: HIV Infections | Phase 4 | Status: COMPLETED